Molecular monitoring of response to imatinib (Glivec®) in CML patients pretreated with interferon alpha. Low levels of residual disease are associated with continuous remission

DOI PDF Web Site 2 Citations

Journal

  • Leukemia

    Leukemia 17 (9), 1687-1694, 2003-09-01

    Springer Science and Business Media LLC

Citations (2)*help

See more

Details 詳細情報について

Report a problem

Back to top